(THRX:Consolidated Issue Listed on NASDAQ Global Select )
Rick E. Winningham
Former Chairman of the Board, Member of Stock Option Committee and Member of Science & Technology Advisory Committee, Theravance Inc.
|Age||Total Calculated Compensation||This person is connected to 72 board members in 5 different organizations across 6 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Rick E. Winningham has been the Chairman and Chief Executive Officer at Theravance Biopharma, Inc. since its spin-off from Theravance, Inc. in June 2014. Mr. Winningham served as the Chief Executive Officer of Theravance Inc. since October 2001 until August 15, 2014. Mr. Winningham served as President of Theravance Inc. since October 2001. From 1997 to 2001, Mr. Winningham served as the President, Bristol-Myers Squibb Oncology /Immunology /Oncology Therapeutics Network ...
951 Gateway BoulevardPhone: 650-238-9600
South San Francisco, California 94080
Board Members Memberships*
Former Chairman of the Board, Member of Stock Option Committee and Member of Science & Technology Advisory Committee
Lead Independent Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Chairman, Chief Executive Officer and Member of Science & Technology Committee
Texas Christian University
Southern Illinois University, Carbondale Campus
|Clive A. Meanwell M.D., Ph.D.||Chairman and Chief Executive Officer|
The Medicines Company
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|$1.5M||Compensation as of Fiscal Year 2014.|